Impact of age on genetics and treatment efficacy in follicular lymphoma.

Stefan Alig,Vindi Jurinovic,Alessandro Pastore,Deepak Bararia,Sarah Häbe,Johannes C Hellmuth,Robert Kridel,Randy Gascoyne,Christian Schmidt, Anna-Katharina Zöllner,Christian Buske,Martin Dreyling,Michael Unterhalt,Wolfgang Hiddemann,Eva Hoster,Oliver Weigert

HAEMATOLOGICA（2018）

引用 14|浏览43

暂无评分

摘要

Defining the impact of age on treatment outcome in patients with follicular lymphoma (FL) is challenging. Age u003e60 years is used as a risk factor in commonly applied risk scores.[1][1],[2][2] However, older patients are, per se, at an increased risk of death due to the natural limits of human

查看译文

关键词

Cytogenetics and Molecular Genetics,Follicular lymphoma,Indolent Non-Hodgkin's Lymphoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要